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of a pandemic at “more than 50
per cent”.
Dr Klaus Stohr, the WHO global
influenza programme chief,
reported an increase in the
number of cluster cases reported
recently, with the biggest being a
family of five cases. There have
been seven cluster cases in
Vietnam, all within single families,
most recently in the northern
province of Haiphong.
No relative has been proved to
have passed the disease to
another in these cases but, Horby
said, “the onset dates could be
consistent with human to human
transmission.”
The WHO hopes to complete
genetic analysis of virus samples
from Cambodia and Vietnam
shortly in order to see if there has
been a significant change in the
make-up of the virus. To date,
there has been human-to-human
transmission but none beyond
‘one or two links in the chain’,
following close contact with a
terminally ill patient.
“The moment we have the
slightest suspicion of a change in
the epidemiology, we would act
very aggressively,” Stohr said.
Based on historical patterns,
influenza pandemics can be
expected to occur, on average,
three to four times each century
when new virus subtypes emerge
and are readily transmitted from
person to person. In the twentieth
century, the flu pandemic of
1918–1919, which killed up to 50
million, was followed by
pandemics in 1957–1958 and
1968–1969. The viruses that
caused these pandemics are all
thought to have derived, at least
in part, from avian strains. Most
influenza experts agree that the
prompt culling of Hong Kong’s
entire 1.5 million poultry
population in 1997 probably
averted a pandemic.
National authorities in south-east
Asia are also monitoring the
situation closely. One victim in
Vietnam, which led to a family
cluster of disease, kept more than
300 chicken and geese in his
backyard. He fell ill with the
disease shortly after some of his
birds contracted it. His three-year-
old daughter and he were
diagnosed with the H5N1 virus and
his wife and two other children
later became ill too. In a
preventative strike, the family’s
entire flock was killed within two
hours of animal health officials
arriving. Poultry within a three-
kilometre radius were put under
surveillance. The family was taken
to an isolation ward and recovered.
The Vietnamese are taking the
outbreak extremely seriously and
have accepted technical help from
the WHO, but its assistance in
field investigations has been
declined.
“We think it is only a matter of
time before H5N1 or a related
strain of the virus becomes
infectious between humans,” said
John Oxford, a virologist at the
Queen Mary and Westfield School
of Medicine in London.
And, at a conference of bird flu
experts in Ho Chi Min City earlier
this spring, further alarm bells
were sounded. The Vietnamese
government was hopeful that its
stringent anti-poultry measures
with farmed birds were beginning
to pay dividends. Since late 2003,
agriculture officials had culled
44 million infected chickens, a
sixth of the country’s poultry
population. And following this
winter’s outbreak, the government
ordered a further 800,000
chickens to be killed, and banned
sale of poultry at Ho Chi Min
City’s markets.
But in spite of these measures,
public health experts at the
conference warned that Vietnam
faced another challenge from the
birds roaming around the paddy
fields and in human contact. In
particular there were concerns
that ducks, according to the latest
evidence, were playing a silent
role in the transmission of the
disease, harbouring the virus and
excreting it in their faeces for up
to 17 days without showing any
obvious signs of illness. “The
public health implications of this
are very serious,” said Shigeru
Omi, the WHO’s Western Pacific
regional coordinator. “How can
people avoid exposure when they
don’t know which ducks are
infected and which are not?”
But the hope is that such fresh
concerns heighten current
activity. “We have to prepare
now,” says Oxford.
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What turned you on to cell
biology in the first place? As a
child I probably would have
chosen to study human or
veterinary medicine rather than
biology. As I lack any fingers on
my right hand because of a birth
defect, medicine was, however,
not an option for me. As a result, I
drifted into an engineering degree,
but hated it and then switched to
biochemistry, which is something I
have never regretted. As an
undergraduate I had really
excellent courses in cell biology
organised by Dan Cutler and Colin
Hopkins, and this is the main
reason why I chose to do a PhD in
cell biology. After sitting through
many hours of lectures about
biochemical pathways, I was
amazed that cells were such
fascinating and dynamic things. As
a postdoc, I learned a lot from
Graham Warren — he was a great
person to have as an advisor.
Has your disability ever been a
problem for your work? No, not
really, except that my lab gloves
don’t fit properly. Scientists are
judged by their achievements
rather than their physical
appearance. This is not true in
many other jobs, which was
something I realised as a student
when I lost a part-time job
because the customers did not
like being served by someone with
a disability.
Do you have a favourite paper?
The series of papers published in
the 1960s in The Journal of Cell
Biology by E.W. Taylor and
colleagues on the mechanism of
action of colchicine, an inhibitor of
mitosis, are amongst my
favourites. Using radiolabelled
colchicine they identified a protein,
later named tubulin, as the target
for colchicine and deduced
correctly that it is a subunit of
microtubules. This was all done in
the age before high-resolution gel
electrophoresis and all the other
tools we take for granted today.
What is the best advice you’ve
been given? I don’t think I have
actually ever been given any
career advice. Maybe people think
I won’t listen to it. My only advice
to students is don’t be afraid of
moving to another country to
pursue career or research goals,
even for a PhD. Despite what
many European students are told,
the USA is not the only option. I
would also encourage students
and postdocs in the USA to come
and work in Europe. Living and
working in Germany as a PhD
student and now as a group leader
with the Max-Planck Society has
been a very positive experience,
and I have met and worked with
many excellent scientists who I
would not have come into contact
with if I had stayed in the UK.
If you knew what you know now
earlier on, would you still
pursue the same career path? In
recent years it has become clear
that a lot of cell biology can only
really be understood in terms of
physiological processes occurring
in organisms. Cell culture has its
limitations. If I had the chance I
would try to get some training in
either mouse or fly developmental
biology. I actually think there is still
time for me to do this, as I won’t be
retiring any time soon.
What has been your biggest
mistake? Trying to work on too
many things at the same time. At
one point shortly after I started my
own group I tried to start yeast
projects in the lab, in addition to
working with mammalian cells.
This was a big mistake and sucked
up huge amounts of time and
resources before I realised a small
research group has to focus its
efforts and stopped the projects.
What is your favourite
conference? Conferences are not
usually bad in that they have bad
science, but bad because they
have become so large in recent
years. Small meetings are really a
much better way to talk with
people and discuss science,
especially for students and
postdocs. I don't have a particular
favourite conference, but I am
probably more likely to attend
meetings where there is a chance
to go skiing. Ski lifts are great
places to talk with people.
Do you have a scientific hero?
Heroes and heroines save lives,
and this is not true of most
scientists or their work. To my
mind, the closest thing to scientific
heroes are scientists such as Sir
James Black, discover of beta-
blockers used to treat coronary
heart disease, and Gertrude Elion
and George Hitchings, discovers
of nucleic acid analogues such as
acyclovir used to combat virus
infections, who jointly received the
Nobel prize for medicine in 1988.
What do you think about the
electronic revolution in
publishing? The change from
paper to electronic publication has
been more of an evolution than a
revolution. The true revolution in
my opinion has been development
of search engines like Entrez-
Pubmed: this is an incredibly
useful tool, and provides a way for
everyone with Internet access to
search the scientific literature. The
problem is that access to this
literature then depends on the
financial situation of the institution
where you work; this was a
problem in the age of paper
journals too, of course. I like the
idea of a freely accessible
centralized archive, like Pubmed
Central, for journal back
catalogues. Some journals actually
handle this well and provide free
access to vast archives of papers
going back to the 1950s, while
others wish to charge for this type
of access in addition to their
normal services. This latter group
of journals should be persuaded to
contribute their back catalogues to
an archive like Pubmed Central. It
would free them up from the costs
of providing access to this
material, which is the only
reasonable reason why they
should be charging.
Do you have any strong views
on journals and the peer review
system? I think all scientists do,
as the pressure to publish in the
highest journals possible has
become so great in recent years.
This has had some negative
effects on the peer review system,
and the temptation for over-
zealous reviewers to be
hypercritical of the work of their
competitors is one example of
this. When writing manuscript
reviews, I set myself the goal that I
would sign my name at the bottom
if necessary. Having said that,
reviewers do need to be protected
from authors, and I think
anonymity of the peer review
process is the only solution.
What is the biggest challenge
facing the scientific
community? Dealing with the ever
increasing amounts of data being
generated, and sorting out what is
correct from what is not. A lot of
emphasis is placed on the
importance of hypotheses to
explain biological processes, but
the quality of the underlying data
is often of secondary importance.
This is an issue that needs to be
addressed before we become
bogged down with bad data.
What is your greatest ambition?
Like most other scientists, it would
be great to discover something
truly novel. As the recent
discoveries of RNA interference
and microRNAs show, there are
probably many still to discover we
have not even dreamed about yet.
A more reasonable ambition is to
crystallize some of the protein
complexes my group works on, so
we can understand how they
function. The combination of
structural biology and cell biology
is very powerful, and I hope my
group will move more in this
direction in future.
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